These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3106416)

  • 1. Inhibition of human endothelial cell proliferation by gold compounds.
    Matsubara T; Ziff M
    J Clin Invest; 1987 May; 79(5):1440-6. PubMed ID: 3106416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of neovascularization in vivo by gold compounds.
    Saura R; Matsubara T; Mizuno K
    Rheumatol Int; 1994; 14(1):1-7. PubMed ID: 7939134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose gold compounds inhibit fibroblast proliferation and do not affect interleukin-1 secretion by macrophages.
    Matsubara T; Saegusa Y; Hirohata K
    Arthritis Rheum; 1988 Oct; 31(10):1272-80. PubMed ID: 3140819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.
    Matsubara T; Saura R; Hirohata K; Ziff M
    J Clin Invest; 1989 Jan; 83(1):158-67. PubMed ID: 2463265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mechanism of action of gold sodium thiomalate in diseases characterized by a proliferative synovitis: reversible changes in collagen production in cultured human synovial cells.
    Goldberg RL; Parrott DP; Kaplan SR; Fuller GC
    J Pharmacol Exp Ther; 1981 Aug; 218(2):395-403. PubMed ID: 6788936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic inhibition of T cell proliferation by gold sodium thiomalate and auranofin.
    Hashimoto K; Whitehurst CE; Lipsky PE
    J Rheumatol; 1994 Jun; 21(6):1020-6. PubMed ID: 7932408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate.
    Hirata S; Matsubara T; Saura R; Tateishi H; Hirohata K
    Arthritis Rheum; 1989 Sep; 32(9):1065-73. PubMed ID: 2476134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic inhibition of human B cell activation by gold sodium thiomalate and auranofin.
    Hirohata S; Nakanishi K; Yanagida T; Kawai M; Kikuchi H; Isshi K
    Clin Immunol; 1999 May; 91(2):226-33. PubMed ID: 10227815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of gold thiomalate on cell proliferation and collagen synthesis of synovial cells in culture.
    Kuttan R
    Indian J Physiol Pharmacol; 1987; 31(4):245-9. PubMed ID: 2836309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of auranofin and gold sodium aurothiomalate on the chemiluminescent response of stimulated synovial tissue cells from patients with rheumatoid arthritis.
    Harth M; McCain GA; Orange JF
    J Rheumatol; 1985 Oct; 12(5):881-4. PubMed ID: 3936929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of gold sodium thiomalate and auranofin on lipopolysaccharide-induced interleukin-1 production by blood monocytes in vitro: variation in healthy subjects and patients with arthritis.
    Danis VA; Kulesz AJ; Nelson DS; Brooks PM
    Clin Exp Immunol; 1990 Mar; 79(3):335-40. PubMed ID: 2107989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of gold sodium thiomalate on the proliferation and interferon-gamma induced HLA-DR expression in human endothelial cells.
    Kawakami A; Eguchi K; Migita K; Nakao H; Otsubo T; Ueki Y; Shimomura C; Tezuka H; Matsunaga M; Ishimaru T
    J Rheumatol; 1990 Apr; 17(4):430-5. PubMed ID: 2112196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of interleukin-2 and interleukin-2 receptor biosynthesis by gold compounds in in vitro activated human peripheral blood mononuclear cells.
    Sfikakis PP; Souliotis VL; Panayiotidis PP
    Arthritis Rheum; 1993 Feb; 36(2):208-12. PubMed ID: 8431210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do gold drugs inhibit interleukin-1? Evidence from an in vitro lymphocyte activating factor assay.
    Haynes DR; Garrett IR; Whitehouse MW; Vernon-Roberts B
    J Rheumatol; 1988; 15(5):775-8. PubMed ID: 3139878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of gold sodium thiomalate on DNA polymerase alpha.
    Takeuchi F; Hanaoka F; Matsuta K; Miyamoto T
    Clin Exp Rheumatol; 1989; 7(6):595-601. PubMed ID: 2515017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of auranofin and sodium aurothiomalate on interleukin-1 production from human monocytes in vitro.
    Remvig L; Enk C; Bligaard N
    Scand J Rheumatol; 1988; 17(4):255-62. PubMed ID: 3142038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of auranofin: overview and update.
    Gottlieb NL
    Scand J Rheumatol Suppl; 1986; 63():19-28. PubMed ID: 3110942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of gold sodium thiomalate on proliferation of human rheumatoid synovial cells and on collagen synthesis in tissue culture.
    Goldberg RL; Parrott DP; Kaplan SR; Fuller GC
    Biochem Pharmacol; 1980 Mar; 29(6):869-76. PubMed ID: 6770866
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C.
    Hashimoto K; Whitehurst CE; Matsubara T; Hirohata K; Lipsky PE
    J Clin Invest; 1992 Jun; 89(6):1839-48. PubMed ID: 1351061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ploidity and cell cycle progression during treatment with gold chloride, auranofin and sodium aurothiomalate. Studies on a human epithelial cell line and its sub-strains made resistant to the antiproliferative effects of these gold compounds.
    Glennås A; Rugstad HE
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 49(4):385-93. PubMed ID: 2867637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.